Industry Bulletins | November 27, 2019
Savonix & Boston University School Of Public Health Launch Landmark Population Health Alzheimer’s Disease Discovery Study
Savonix, a global leader in digital tests for cognitive health, and Boston University School of Public Health announced the launch of a landmark population health study in dementia. The Alzheimer’s Disease Discovery Study (ASSIST) Study will digitally collect cognitive data, health history, and lifestyle tracking data from 400,000 individuals.
Study participants will complete a short health history form to collect information on risk factors for the development of dementia such as smoking, alcohol intake, diet, and exercise. Digital devices will record and gather information as sleep patterns, heart rate variability, exercise, blood glucose levels, and other critical bio . . .